Screener
Beta Bionics BBNX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 700,000,000 shares authorized; 44,981,606 and 44,360,873 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 5 | 4 |
| Additional paid-in capital | 671,986 | 657,140 |
| Accumulated other comprehensive income (loss) | (390) | 403 |
| Accumulated deficit | (415,235) | (369,937) |
| Total stockholders’ equity | 256,366 | 287,610 |
| Total liabilities and stockholders’ equity | $292,387 | $328,743 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total liabilities & equity?
- Beta Bionics (BBNX) reported total liabilities & equity of $292.39M in Q2 2026.
- How has Beta Bionics's total liabilities & equity changed year-over-year?
- Beta Bionics's total liabilities & equity decreased by 11.4% year-over-year, from $329.97M to $292.39M.
- What is the long-term trend for Beta Bionics's total liabilities & equity?
- Over 2 years (2023 to 2025), Beta Bionics's total liabilities & equity has grown at a 72.8% compound annual growth rate (CAGR), from $110.04M to $328.74M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Beta Bionics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude